Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications
- PMID: 20704763
- PMCID: PMC2927496
- DOI: 10.1186/1743-8454-7-12
Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications
Abstract
Background: During Chikungunya virus (CHIKV) epidemic in Nagpur, India, we identified some suspected Chikungunya patients with neurological complications. Early and cost-effective diagnosis of these patients remains problematic despite many new advanced diagnostic methods. A reliable diagnostic test, which could be performed in any standard pathology laboratory, would help to obtain definitive early diagnosis of CHIKV patients with neurological complications. In our laboratory, in-house ELISA protocol for viral antigen, immunoglobulin M (IgM) and IgG detection has been developed and assessed for the diagnosis of CHIKV patients with neurological complications.
Method: Cerebrospinal fluid samples of forty-six patients who developed neurological symptoms within two months of CHIKV infections along with control subjects were included in the study and were analyzed for the presence of antigens and of IgM and IgG using an ELISA protocol.
Results: The ELISA method for antigen detection yielded 80% sensitivity and 87% specificity for the diagnosis of CHIKV patients with neurological complications. The sensitivity for detection of IgM 48% or IgG 63% was significantly lower than the antigen assay (80%).
Conclusion: The detection of viral antigen in CSF of CHIKV patients with neurological complications by ELISA method gave a more reliable diagnosis than antibodies detection that can be used to develop an immunodiagnostic assay with increased sensitivity and specificity.
Figures
Similar articles
-
Diagnosis of Chikungunya fever in an Indian population by an indirect enzyme-linked immunosorbent assay protocol based on an antigen detection assay: a prospective cohort study.Clin Vaccine Immunol. 2010 Feb;17(2):291-7. doi: 10.1128/CVI.00326-09. Epub 2009 Dec 9. Clin Vaccine Immunol. 2010. PMID: 20007365 Free PMC article.
-
Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.Virol J. 2018 Jul 24;15(1):112. doi: 10.1186/s12985-018-1028-1. Virol J. 2018. PMID: 30041676 Free PMC article.
-
Comparative evaluation of the diagnostic potential of recombinant envelope proteins and native cell culture purified viral antigens of Chikungunya virus.J Med Virol. 2014 Jul;86(7):1169-75. doi: 10.1002/jmv.23752. Epub 2013 Sep 16. J Med Virol. 2014. PMID: 24105844
-
Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.Immunol Invest. 2017 Aug;46(6):552-565. doi: 10.1080/08820139.2017.1319383. Epub 2017 Jul 25. Immunol Invest. 2017. PMID: 28742401
-
Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.Clin Vaccine Immunol. 2015 Mar;22(3):291-7. doi: 10.1128/CVI.00720-14. Epub 2014 Dec 24. Clin Vaccine Immunol. 2015. PMID: 25540275 Free PMC article.
Cited by
-
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.EMBO Mol Med. 2015 Jan;7(1):24-41. doi: 10.15252/emmm.201404459. EMBO Mol Med. 2015. PMID: 25452586 Free PMC article.
-
Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection.Appl Microbiol Biotechnol. 2020 Apr;104(8):3209-3228. doi: 10.1007/s00253-020-10437-x. Epub 2020 Feb 19. Appl Microbiol Biotechnol. 2020. PMID: 32076776 Free PMC article. Review.
-
Molecular Characterisation of Clinical Isolates of Chikungunya Virus: A Study from Tertiary Care Hospitals in Southern India.J Clin Diagn Res. 2016 Mar;10(3):DC14-7. doi: 10.7860/JCDR/2016/18370.7509. Epub 2016 Mar 1. J Clin Diagn Res. 2016. PMID: 27134872 Free PMC article.
-
Chikungunya encephalitis: report of a fatal case in Northeastern Brazil.Rev Inst Med Trop Sao Paulo. 2020 Jun 17;62:e40. doi: 10.1590/S1678-9946202062040. eCollection 2020. Rev Inst Med Trop Sao Paulo. 2020. PMID: 32578726 Free PMC article.
-
Cerebrospinal Fluid Immunoglobulins as Potential Biomarkers of Chikungunya Encephalitis.Emerg Infect Dis. 2018 May;24(5):939-941. doi: 10.3201/eid2405.171763. Emerg Infect Dis. 2018. PMID: 29664389 Free PMC article.
References
-
- Yadav P, Shouche YS, Munot HP, Mishra AC, Mourya DT. Genotyping of Chikungunya virus isolates from India during 1963-2000 by reverse transcription-polymerase chain reaction. Acta Virol. 1963;47:125–127. - PubMed
-
- Saxena SK. Reemergence of the knotty Chikungunya virus: facts, fears or fiction. Editorial Fut Virol. 2007;2:121–126. doi: 10.2217/17460794.2.2.121. - DOI
-
- Kumar K, Chhabra M, Katyal R, Patnaik PK, Kukreti H, Rai A, Saxena VK, Mittal V, Lal S. Investigation of an outbreak of chikungunya in Malegaon Municipal areas of Nasik district, Maharashtra (India) and its control. J Vector Borne Dis. 2008;45:157–163. - PubMed
LinkOut - more resources
Full Text Sources